Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP801818.RA8aAGhtRVKaMnNP8tLlleuVjreTeqzb-goAOVlkMFQLg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP801818.RA8aAGhtRVKaMnNP8tLlleuVjreTeqzb-goAOVlkMFQLg130_assertion type Assertion NP801818.RA8aAGhtRVKaMnNP8tLlleuVjreTeqzb-goAOVlkMFQLg130_head.
- NP801818.RA8aAGhtRVKaMnNP8tLlleuVjreTeqzb-goAOVlkMFQLg130_assertion description "[Particularly significant differences were observed as to the expression of PTEN (p < 0.0001), TP53 (p = 0.0003), PIK3CA (p = 0.0003) and BECN1 (p = 0.0014) which were shown to be downregulated in cancer patients when compared to healthy ovaries and benign ovarian cysts (endometrial and simple).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP801818.RA8aAGhtRVKaMnNP8tLlleuVjreTeqzb-goAOVlkMFQLg130_provenance.
- NP801818.RA8aAGhtRVKaMnNP8tLlleuVjreTeqzb-goAOVlkMFQLg130_assertion evidence source_evidence_literature NP801818.RA8aAGhtRVKaMnNP8tLlleuVjreTeqzb-goAOVlkMFQLg130_provenance.
- NP801818.RA8aAGhtRVKaMnNP8tLlleuVjreTeqzb-goAOVlkMFQLg130_assertion SIO_000772 21744334 NP801818.RA8aAGhtRVKaMnNP8tLlleuVjreTeqzb-goAOVlkMFQLg130_provenance.
- NP801818.RA8aAGhtRVKaMnNP8tLlleuVjreTeqzb-goAOVlkMFQLg130_assertion wasDerivedFrom befree-20150227 NP801818.RA8aAGhtRVKaMnNP8tLlleuVjreTeqzb-goAOVlkMFQLg130_provenance.
- NP801818.RA8aAGhtRVKaMnNP8tLlleuVjreTeqzb-goAOVlkMFQLg130_assertion wasGeneratedBy ECO_0000203 NP801818.RA8aAGhtRVKaMnNP8tLlleuVjreTeqzb-goAOVlkMFQLg130_provenance.